Sign In
Buy ACT
$40.57
-0.580 (-1.41%)
At Close: Jun 03, 2026
BRIEF-Ironwood, Allergan Receive Notices Of Allowance For Patent Applications Covering 72 MCG Dose Of Linzess
08:45pm, Tuesday, 28'th Apr 2020
Allergan plc:
Announcement relating to the voluntary delisting of Allergan Notes
08:30pm, Tuesday, 28'th Apr 2020
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTIO
Ironwood and Allergan Receive Notices of Allowance for Patent Applications Covering 72 mcg Dose of LINZESS (linaclotide)
08:05pm, Tuesday, 28'th Apr 2020
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for patent applications covering the formulatio
Buy Allergan Stock as Big Pharma’s Biggest Deal Is About to Close
06:26pm, Tuesday, 28'th Apr 2020
Don't let the pandemic distract your attention from a monster acquisition -- and a chance to own Allergan stock before the deal's finalized.
Allergan (AGN) Earnings Expected to Grow: Should You Buy?
04:33pm, Tuesday, 28'th Apr 2020
Allergan (AGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allergan (AGN) Earnings Expected to Grow: Should You Buy?
04:33pm, Tuesday, 28'th Apr 2020
Allergan (AGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
03:52pm, Tuesday, 28'th Apr 2020
AbbVie's (ABBV) Q1 top line is likely to have been impacted by biosimilar competition for Humira in international markets. However, oncology drugs may have demonstrated strong growth.
Form 8.3 - Allergan plc
02:15pm, Tuesday, 28'th Apr 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MO
Allergan plc (NYSE:AGN) Stake Lessened by Delta Financial Advisors LLC
10:52am, Tuesday, 28'th Apr 2020
Delta Financial Advisors LLC cut its stake in Allergan plc (NYSE:AGN) by 60.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The i
Karuna Therapeutics Appoints Christopher J. Coughlin to its Board of Directors
10:00am, Tuesday, 28'th Apr 2020
Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and pote
Allergan plc (NYSE:AGN) Shares Sold by Duncker Streett & Co. Inc.
09:34am, Tuesday, 28'th Apr 2020
Duncker Streett & Co. Inc. reduced its holdings in Allergan plc (NYSE:AGN) by 62.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 1,270 shares of the company’s stock after selling
Ironwood and Allergan get notice of allowance for LINZESS patent applications IRWD;AGN
09:14am, Tuesday, 28'th Apr 2020
Ironwood and Allergan get notice of allowance for LINZESS patent applications IRWD AGN
The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors
09:01am, Tuesday, 28'th Apr 2020
The coronavirus has completely changed the narrative regarding AbbVie’s buyout of AGN.
Form 8.3 -
02:26pm, Monday, 27'th Apr 2020
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
